SCHEMBL28589056

SCHEMBL28589056

CC(C)[C@H](N)C(=O)OCc1ccc(Br)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.47
MAPT P10636 3/20 0.47
ALDH1A1 P00352 2/20 0.47
HPGD P15428 1/20 0.47
KMT2A Q03164 3/20 0.46
EPHX1 P07099 2/20 0.45
SLC15A1 P46059 1/20 0.45
MEN1 O00255 1/20 0.44
IDO1 P14902 2/20 0.44
MAOB P27338 1/20 0.43
MMP1 P03956 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
RXRA P19793 1/20 0.41
RXRB P28702 1/20 0.41
FABP7 O15540 1/20 0.40
FABP5 Q01469 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28589062 1.00 KDM4E (0.47) KDM4EMAPTALDH1A1HPGDKMT2A
SCHEMBL24785638 0.85 RAB9A (0.46) KDM4EMAPTALDH1A1SLC15A1MAOB
SCHEMBL13485170 0.85 RAB9A (0.46) KDM4EMAPTALDH1A1SLC15A1MAOB
SCHEMBL8861375 0.83 KMT2A (0.46) KDM4EMAPTALDH1A1HPGDKMT2A
SCHEMBL6009112 0.83 KMT2A (0.46) KDM4EMAPTALDH1A1HPGDKMT2A
SCHEMBL19582027 0.83 SLC15A1 (0.45) KDM4EMAPTKMT2ASLC15A1MEN1
SCHEMBL24049985 0.83 CYP3A4 (0.50) KDM4EMAPTALDH1A1KMT2ASLC15A1
SCHEMBL28265839 0.83 SLC15A1 (0.45) ALDH1A1KMT2ASLC15A1MEN1
SCHEMBL8254586 0.83 SLC15A1 (0.45) KDM4EMAPTKMT2ASLC15A1MEN1
SCHEMBL542444 0.83 SLC15A1 (0.61) ALDH1A1KMT2ASLC15A1MEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112939814-B Preparation method of deuterated dacarbazine intermediate 正大天晴药业集团股份有限公司 2023-09-29 CN disclosed
CN-112939814-A Preparation method of deuterated daclatasvir intermediate 正大天晴药业集团股份有限公司 2021-06-11 CN disclosed